455.80
-0.91%
Close of 9 Nov 2026, in DKK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Novozymes A/S
Its shares trade on Nasdaq Copenhagen under the ticker NSIS B.CO. It has been listed since 27 May 1905.
Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 27 May 1905
- Employees
- 6,066
- Website
- novozymes.com ↗
Leadership
Pay as last reported
- Mr. Cees De JongIndependent Chairman of the Board€329,300
- Ms. Ester BaigetPresident, Chief Executive Officer€6.8m
- Mr. Heine DalsgaardVice Chairman of the Board, since 2020€176,600
- Mr. Rainer LehmannChief Financial Officer, Executive Vice President€2.9m
- Mr. Robert JensenDirector - Employee Representative
- Mr. Lars KopplerDirector - Employee Representative, since 2025DKK 99,000
- Ms. Monila KothariDirector
- Mr. Kasim KutayDirector€109,800
- Mr. Preben NielsenDirector, Employee Representative€109,800
- Ms. Frederikke SpennerDirector - Employee Representative
- Mr. Morten Otto Alexander SommerIndependent Director€116,200
- Ms. Lise KaaeIndependent Director€90,500
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 84
- Environment
- 99
- Social
- 99
- Governance
- 53
- Direct emissions (scope 1)
- 93,549 t
- Energy emissions (scope 2)
- 351,812 t
- Value chain emissions (scope 3)
- 1,405,943 t
- Women in the workforce
- 41.23039%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Novozymes A/S has several strengths that contribute to its competitive advantage. First and foremost, the company is a global leader in the production of enzymes. With more than 70 years of experience in research and development, Novozymes has established a strong reputation for high-quality, innovative products.
- Another strength is the company's focus on sustainability. Novozymes is committed to developing enzyme solutions that help reduce environmental impact and enable cleaner and more sustainable processes in various industries, including agriculture, household care, and bioenergy.
Weaknesses
- Despite its strengths, Novozymes A/S also faces some weaknesses that could hinder its growth and performance. One weakness is the company's dependence on a few key customers. If these customers were to reduce their orders or switch to alternative suppliers, Novozymes may experience revenue fluctuations.
- Additionally, Novozymes faces intense competition from other enzyme manufacturers. Maintaining market share and pricing power can be challenging in such a competitive landscape.
Opportunities
- Novozymes has several opportunities for growth and expansion. One opportunity lies in the increasing demand for sustainable solutions, driven by environmental concerns and regulatory changes. Novozymes can leverage its expertise in enzymes to capture a larger market share in industries transitioning towards greener processes and products.
- Furthermore, the company can explore new geographic markets, particularly in emerging economies where the demand for enzymes is expected to rise along with industrialization.
Threats
- Novozymes faces certain threats that could impact its performance and profitability. One significant threat is the risk of regulatory changes. Shifts in environmental regulations or trade policies can affect the demand for certain enzyme applications or disrupt global supply chains, potentially leading to market uncertainties.
- Another threat is the rapid pace of technological advancements. Novozymes must stay at the forefront of research and development to ensure its enzyme solutions remain competitive and aligned with industry needs.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.